Today: 7 February 2026
Subscribe

IonQ stock rises today after South Korea seals 100-qubit quantum system deal

IonQ stock rises today after South Korea seals 100-qubit quantum system deal

NEW YORK, December 30, 2025, 14:31 ET — Regular session IonQ, Inc. shares were up 1.3% at $45.83 in regular trading on Tuesday after the company said it finalized an agreement to deliver a 100-qubit Tempo quantum system to South Korea’s Korea Institute of Science and Technology Information (KISTI). The stock has traded between $45.48 and $47.40, with volume around 9.3 million shares. IonQ said the system will be integrated into KISTI-6 “HANGANG,” a high-performance computing (HPC) cluster, in what it described as the country’s first on-site hybrid quantum-classical setup; CEO Niccolo de Masi called the deal “a defining moment
30 December 2025
·····
Freeport-McMoRan stock today: FCX edges up as copper rebounds toward record highs

Freeport-McMoRan stock today: FCX edges up as copper rebounds toward record highs

NEW YORK, December 30, 2025, 2:22 PM ET — Regular session Freeport-McMoRan shares rose about 0.5% to $51.75 in afternoon trading on Tuesday, after swinging between $50.87 and $52.67 earlier in the session. The move matters because Freeport’s earnings tend to track copper prices closely. When the metal rises, miners typically see higher revenue per pound sold, which can lift cash generation. Copper’s year-end rally has put the spotlight back on supply tightness and demand tied to electrification and the buildout of power-hungry data centers. That backdrop has helped keep interest in large, liquid copper names such as Freeport. U.S.
30 December 2025
····
Why Karman Holdings Stock Is Down Today: KRMN Slides as Year-End Flows Hit Defense-Space Names

Why Karman Holdings Stock Is Down Today: KRMN Slides as Year-End Flows Hit Defense-Space Names

NEW YORK, December 30, 2025, 14:21 ET — Regular session Karman Holdings Inc. shares were down 3.6% at $74.81 in afternoon trading on Tuesday, after touching $74.21 at the session low. The stock traded as high as $78.55, with about 465,000 shares changing hands. The dip comes in the final week of the year, when thinner liquidity can exaggerate moves in individual stocks. “It’s just a healthy rebalancing of allocations more so than an emotionally driven sell-off,” said Mark Hackett, chief market strategist at Nationwide, in a broader market note on holiday-thin trading. Fund flows have also become a near-term
30 December 2025
·····
CRH stock dips today as buyback rolls on and Fed minutes loom

CRH stock dips today as buyback rolls on and Fed minutes loom

NEW YORK, December 30, 2025, 14:02 ET — Regular session Shares of CRH plc (CRH) fell about 1.1% to $126.01 in afternoon New York trading on Tuesday after the building materials group disclosed another day of repurchases under its U.S. buyback program. CRH said it bought 31,100 shares on Monday at a volume-weighted average price of $127.33, paying between $126.46 and $128.87, and will cancel the shares as part of a plan to repurchase up to $300 million of stock by Feb. 17. The stock traded between $125.92 and $127.25 on Tuesday. Business Wire The move matters now because CRH
30 December 2025
···
Zenas BioPharma stock slides 5% today as biotech shares sag; Phase 3 INDIGO data in focus

Zenas BioPharma stock slides 5% today as biotech shares sag; Phase 3 INDIGO data in focus

NEW YORK, December 30, 2025, 02:05 PM ET — Regular session Zenas BioPharma Inc shares fell $2.02, or 5.2%, to $37.03 in afternoon trading on Tuesday, after ending the prior session at $39.05. The stock ranged from $36.94 to $40.50, with about 123,000 shares traded. The drop came as biotech stocks eased in thin year-end trading, with the Nasdaq Biotechnology Index down about 1%. That matters now because smaller, cash-burning drug developers often move with risk appetite as much as on headlines. indexes.nasdaqomx.com Wall Street’s main indexes were largely muted as investors waited for minutes from the Federal Reserve’s December
30 December 2025
······
Schwab stock slips as Fed minutes put rate outlook back in focus

Schwab stock slips as Fed minutes put rate outlook back in focus

NEW YORK, December 30, 2025, 14:00 ET — Regular session The Charles Schwab Corp’s shares were down 0.6% at $100.69 in afternoon trading on Tuesday, after opening at $101.58 and trading between $100.34 and $101.60. The broader market was little changed, while rivals Interactive Brokers and Robinhood also traded lower. The move matters because Schwab earns a large share of its revenue from client cash, making the stock sensitive to shifts in interest-rate expectations. That sensitivity can show up quickly on quiet days, when small changes in rate bets have an outsized impact on financial stocks. Investors are also looking
30 December 2025
·······
KLA stock dips as China’s 50% domestic chip-tool rule rattles semiconductor equipment names

KLA stock dips as China’s 50% domestic chip-tool rule rattles semiconductor equipment names

NEW YORK, December 30, 2025, 14:00 ET — Regular session Shares of KLA Corp fell about 0.8% to $1,250.43 on Tuesday, after a Reuters report said China is requiring chipmakers seeking approval for new or expanded plants to show at least half their equipment will be sourced domestically. The stock traded between $1,249.69 and $1,273.20. Reuters The China headline matters for KLA because chipmaking tools are a long-cycle business: policy shifts can change where fabs (chip factories) buy equipment and how quickly foreign suppliers lose share. For investors, the risk is less about one quarter and more about visibility into
30 December 2025
·······
BETA Technologies stock slides in year-end trade: what’s driving the move and what investors watch next

BETA Technologies stock slides in year-end trade: what’s driving the move and what investors watch next

NEW YORK, December 30, 2025, 14:01 ET — Regular session Shares of BETA Technologies, Inc. (BETA) fell 3.4% to $28.46 in afternoon trading on Tuesday after opening at $29.82, leaving the stock near the day’s low of $28.37. The session high was $29.79, with about 304,000 shares traded. The drop came as U.S. stocks held near flat in choppy, holiday-thinned trading, with investors focused on minutes from the Federal Reserve’s Dec. 9-10 meeting due later in the day. “It’s just a healthy rebalancing of allocations more so than an emotionally driven sell-off,” said Mark Hackett, chief market strategist at Nationwide.
30 December 2025
·····
Marvell stock rises today as Fed minutes loom — and a CES CEO chat is next

Marvell stock rises today as Fed minutes loom — and a CES CEO chat is next

NEW YORK, December 30, 2025, 13:29 ET — Regular session Marvell Technology (MRVL) shares rose 1.1% to $86.74 in early afternoon trading on Tuesday, after swinging between $85.58 and $88.07. The move matters because Marvell sits in the center of spending on AI data centers, an area where budgets and valuations tend to react quickly when interest-rate expectations shift. Traders were also bracing for thin, year-end liquidity, which can amplify intraday moves. Reuters Investors also have a near-term company catalyst: a Jan. 6 CES fireside chat hosted by J.P. Morgan with Marvell CEO Matt Murphy, the company’s investor relations calendar
30 December 2025
····
BitMine (BMNR) stock slips as firm touts 4.11 million ether stash ahead of Jan. 15 vote

BitMine (BMNR) stock slips as firm touts 4.11 million ether stash ahead of Jan. 15 vote

NEW YORK, December 30, 2025, 14:01 ET — Regular session Shares of BitMine Immersion Technologies Inc were down about 0.8% at $28.32 by 2:01 p.m. ET on Tuesday, with volume around 18.0 million shares. In a press release filed with the SEC, the NYSE American-listed firm said its Ethereum holdings reached 4.11 million ether (ETH), part of $13.2 billion of crypto and cash, ahead of a Jan. 15 shareholder meeting. “Year-end tax-loss related selling is pushing down crypto and crypto equity prices,” chairman Thomas “Tom” Lee said. SEC The update matters because BitMine has turned itself into an “Ethereum treasury”
30 December 2025
·····
Arrowhead Pharmaceuticals stock slides today as biotech dips; ARWR investors eye January obesity data

Arrowhead Pharmaceuticals stock slides today as biotech dips; ARWR investors eye January obesity data

NEW YORK, December 30, 2025, 13:47 ET — Regular session Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) shares were down 3.6% at $67.09 at 1:47 p.m. ET on Tuesday, after trading between $65.94 and $69.95. The stock’s drop came as biotech weakened but the wider market held steady, a setup that can amplify moves in higher-volatility drug developers. The SPDR S&P Biotech ETF (XBI) fell 1.3% and the iShares Nasdaq Biotechnology ETF (IBB) dropped 1.1%, while the S&P 500 tracker SPY was flat and the Nasdaq-100 proxy QQQ edged higher. The timing matters because Arrowhead is heading into an early-January news window where
30 December 2025
····
Wells Fargo stock slips as Fed minutes loom in thin year-end trading

Wells Fargo stock slips as Fed minutes loom in thin year-end trading

NEW YORK, December 30, 2025, 13:55 ET — Regular session. Wells Fargo & Company shares slipped on Tuesday as U.S. financial stocks eased in holiday-thin trading ahead of the Federal Reserve’s meeting minutes. At 1:55 p.m. ET, Wells Fargo (NYSE:WFC) was down about 0.4% at $94.15, after trading between $94.00 and $95.00 on the session. Reuters The move matters because bank stocks tend to key off interest-rate expectations. Rates drive net interest income — the spread between what banks earn on loans and what they pay on deposits — and even small changes in that spread can swing earnings forecasts.
30 December 2025
····
1 … 1,083 1,084 1,085 1,086 1,087 … 2,711

Stock Market Today

Vodafone shares steady up after Q3 wobble — Germany, buyback and next results now set the tone

Vodafone shares steady up after Q3 wobble — Germany, buyback and next results now set the tone

7 February 2026
Vodafone shares rose 1.47% to 110.60p Friday, recovering part of Thursday’s 4.68% drop after a Q3 update. Group revenue climbed 6.5% to €10.5 billion, but Germany’s 0.7% service revenue growth missed some forecasts. Vodafone launched a new €500 million buyback tranche, bringing total buybacks since May to €3.5 billion. Investors remain focused on Germany’s pace and cash flow execution.
NatWest Group stock: buyback filing and Rightmove mortgage deal set up a busy week

NatWest Group stock: buyback filing and Rightmove mortgage deal set up a busy week

7 February 2026
NatWest shares closed up 1.45% at 659.4 pence Friday, buoyed by a buyback of 797,428 shares and a new digital mortgage deal with Rightmove. The Bank of England held rates at 3.75% but signaled possible cuts, with markets pricing in two reductions for 2026. NatWest plans to expand its Accelerator community to 50,000 members by 2026. Annual results are due Feb. 13.
Unilever share price holds at 5,250p as results week looms — what investors watch next

Unilever share price holds at 5,250p as results week looms — what investors watch next

7 February 2026
Unilever shares closed flat at 5,250p in London Friday, underperforming the FTSE 100’s 0.6% gain. The company issued 4.2 million new shares for employee plans, bringing total shares to over 2.18 billion. Investors await Q4 and full-year results on Feb. 12, with analyst consensus pointing to 3.9% Q4 sales growth. Unilever’s U.S. ADR rose 0.8% to $72.12.
BP share price near 52-week high ahead of Feb 10 earnings as buyback runs on

BP share price near 52-week high ahead of Feb 10 earnings as buyback runs on

7 February 2026
BP shares closed up 1.9% at 478 pence Friday, just below a 52-week high, as the company continued buybacks ahead of next week’s results. BP repurchased 2.789 million shares on February 6. Oil prices firmed on geopolitical risk, with Brent at $68.05 a barrel, but sector outlook remains uncertain. Investors await BP’s earnings and dividend decision due Tuesday.
Go toTop